We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$634M
AUM Growth
+$113M
Cap. Flow
+$79.5M
Cap. Flow %
12.54%
Top 10 Hldgs %
42.47%
Holding
197
New
65
Increased
36
Reduced
30
Closed
49

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.1M
2
AMZN icon
Amazon
AMZN
+$13.4M
3
SNPS icon
Synopsys
SNPS
+$8.98M
4
KNX icon
Knight Transportation
KNX
+$8.3M
5
AMRS
Amyris Inc.
AMRS
+$8.01M

Sector Composition

Rank Sector Weight
1 Technology 29.88%
2 Healthcare 13.86%
3 Industrials 10.8%
4 Consumer Discretionary 4.6%
5 Consumer Staples 4.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PD icon
126
PagerDuty
PD
$821M
$236K 0.04%
+5,000
New +$243K
ALDR
127
DELISTED
Alder Biopharmaceuticals
ALDR
$235K 0.04%
20,000
-10,000
-33% -$121K
AMAT icon
128
Applied Materials
AMAT
$359B
$225K 0.04%
+5,000
New +$211K
LPSN icon
129
LivePerson
LPSN
$22.6M
$224K 0.04%
+533
New +$227K
MGNI icon
130
Magnite
MGNI
$2.83B
$222K 0.04%
+35,000
New +$215K
AZRE
131
DELISTED
Azure Power Global Limited
AZRE
$209K 0.03%
20,000
ABEO icon
132
Abeona Therapeutics
ABEO
$342M
$190K 0.03%
1,600
+400
+33% +$67.1K
SIEN
133
DELISTED
Sientra, Inc.
SIEN
$166K 0.03%
+2,700
New +$194K
APEN
134
DELISTED
Apollo Endosurgery, Inc.
APEN
$155K 0.02%
48,688
CBAY
135
DELISTED
Cymabay Therapeutics
CBAY
$143K 0.02%
20,000
-21,000
-51% -$238K
PTE
136
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
$143K 0.02%
1,000
IEA
137
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$124K 0.02%
60,603
-17,874
-23% -$67.5K
VATE icon
138
INNOVATE Corp
VATE
$101M
$119K 0.02%
+5,000
New +$123K
CGRN
139
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$118K 0.02%
15,000
SEEL
140
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$110K 0.02%
13
+3
+30% +$31.6K
NEPT
141
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$109K 0.02%
18
TAST
142
DELISTED
Carrols Restaurant Group, Inc.
TAST
$91K 0.01%
+10,000
New +$91.8K
NVTR
143
DELISTED
Nuvectra Corporation Common Stock
NVTR
$84K 0.01%
25,095
BNED icon
144
Barnes & Noble Education
BNED
$439M
$57K 0.01%
+170
New +$65.3K
NOK icon
145
Nokia
NOK
$47.8B
$55K 0.01%
+11,000
New +$57.9K
GE icon
146
GE Aerospace
GE
$368B
$47K 0.01%
903
+100
+12% +$4.92K
CORV
147
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$27K ﹤0.01%
12,500
+2,134
+21% +$5.45K
ATNM icon
148
Actinium Pharmaceuticals
ATNM
$26.7M
$19K ﹤0.01%
2,500
AIRG icon
149
Airgain
AIRG
$70.7M
-25,000
Closed -$321K
AMZN icon
150
Amazon
AMZN
$2.45T
-150,000
Closed -$13.4M

Similar funds

Ardsley Advisory Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Ardsley Advisory Partners held 197 positions worth $634M, up 22% from $521M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $79.5M of net new capital in Q2 2019, opening 65 new positions and adding to 36 existing holdings. Its largest new stake was Organigram Holdings: 250,000 shares worth $6.44M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Celgene Corp, an estimated $25.1M trimmed.

  • Ardsley Advisory Partners's largest Q2 2019 buy was Organigram Holdings: 250,000 shares worth $6.44M.
  • Ardsley Advisory Partners added most to Walt Disney in Q2 2019, an estimated $17.1M increase.
  • Ardsley Advisory Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
  • Ardsley Advisory Partners fully exited Amazon in Q2 2019, selling an estimated $13.4M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $634M portfolio in Q2 2019.
  • Ardsley Advisory Partners opened 65 new positions and closed 49 in Q2 2019.
  • Ardsley Advisory Partners's portfolio value rose 22% quarter-over-quarter to $634M.

Based on Ardsley Advisory Partners's 13F filing for Q2 2019, filed 13 Aug 2019.